Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

Hair problems can be caused by genetics or the environment, and treatment should focus on the cause and reducing hair damage.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Three drugs change mice's alcohol drinking patterns by affecting GABAA receptors.

Iontophoresis improves minoxidil delivery for alopecia treatment.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Polyamines are important for hair growth, but more research is needed to understand their functions and treatment potential.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

SHBG binding properties are unchanged in male liver cirrhosis patients.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Safflower has been used in traditional medicine for centuries and shows promise in treating heart, brain, and inflammatory conditions, but more research is needed to ensure its safety.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Iontophoresis improves minoxidil delivery to hair follicles for hair loss treatment.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Red clover extract improved hair, skin, mood, sleep, and tiredness in postmenopausal women.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

Progesterone and its byproducts control a specific receptor in the brain independently of progesterone receptors, affecting conditions related to the menstrual cycle.

Biotin supplements improved skin and hair problems in a girl with biotinidase deficiency.